Pancreatic Cancer Research

ResearcherKyushu UniversityNo recent work listed

Ryota Matsuda

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8677-1890; OpenAlex author ID A5064468700. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2019: 1 paper · 2020: 5 papers · 2021: 1 paper

Papers 7

  1. Collision of a pancreatic ductal adenocarcinoma and a pancreatic neuroendocrine tumor associated with multiple endocrine neoplasm type 1. Co-author DOI 10.1007/s12328-020-01234-0↗
  2. Is remnant pancreatic cancer after pancreatic resection more frequent in early-stage pancreatic cancer than in advanced-stage cancer? Co-author DOI 10.1002/ags3.12340↗
  3. Chronic inflammatory changes and oxidative stress in the background of "pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neopla… Co-author DOI 10.1007/s00428-020-02844-2↗
  4. High-risk lesions in the remnant pancreas: fate of the remnant pancreas after pancreatic resection for pancreatic cancer and intraductal papillary mucinous neo… Co-author DOI 10.1007/s00595-019-01852-3↗
  5. Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in… Co-author DOI 10.1097/sla.0000000000003060↗
  6. FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients. Co-author DOI 10.7150/jca.38399↗
  7. Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer Potentially Improves Survival and Facilitates Surgery. Co-author DOI 10.1245/s10434-019-07309-8↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masafumi Nakamura · 6 shared papers, 2020–2021 · strength 0.66
  2. Yoshihiro Miyasaka · 6 shared papers, 2019–2020 · strength 0.63
  3. Yoshinao Oda · 6 shared papers, 2019–2021 · strength 0.62
  4. Takao Ohtsuka · 5 shared papers, 2019–2021 · strength 0.55
  5. Yasuhisa Mori · 3 shared papers, 2019–2020 · strength 0.33
  6. Kohei Nakata · 3 shared papers, 2019–2020 · strength 0.33
  7. Kiyoshi Saeki · 3 shared papers, 2020 · strength 0.30
  8. Nao Fujimori · 2 shared papers, 2019–2021 · strength 0.21
  9. Ryuichiro Kimura · 2 shared papers, 2019–2020 · strength 0.20
  10. Kenoki Ohuchida · 1 shared paper, 2020 · strength 0.13
  11. Tetsuhide Ito · 1 shared paper, 2021 · strength 0.12
  12. Hisato Igarashi · 1 shared paper, 2021 · strength 0.12
  13. Masami Miki · 1 shared paper, 2021 · strength 0.12
  14. Akihisa Ohno · 1 shared paper, 2021 · strength 0.12
  15. Yoshihiro Ogawa · 1 shared paper, 2021 · strength 0.12
  16. Masato Watanabe · 1 shared paper, 2020 · strength 0.11
  17. Yasuhiro Oyama · 1 shared paper, 2020 · strength 0.10
  18. Makoto Kawamoto · 1 shared paper, 2020 · strength 0.10
  19. Yoshinao Oda · 1 shared paper, 2020 · strength 0.10
  20. Koji Shindo · 1 shared paper, 2020 · strength 0.10
  21. Hideya Onishi · 1 shared paper, 2020 · strength 0.10
  22. Masafumi Nakamura · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.